Literature DB >> 27737600

Update on bipolar disorder biomarker candidates.

Antonio L Teixeira1, Haitham Salem1, Benicio N Frey2,3, Izabela G Barbosa4, Rodrigo Machado-Vieira5.   

Abstract

INTRODUCTION: Bipolar disorder is a chronic and disabling mood disorder with a complex pathophysiological basis. A significant percentage of patients do not receive correct diagnosis which directly influences therapeutic response, rendering recovery troublesome. There is a long-standing need for proper non-clinically based tools for diagnosis, treatment selection and follow-up of such patients. Areas covered: In the past decade, the scientific community has shown a great interest in biomarker development. Here, we highlight the different potential biomarkers and we discuss their feasibility and their possible clinical relevance. Expert commentary: To date, despite the major ongoing trials and consortia with promising future perspectives, no reliable biomarker of bipolar disorder has been fully defined.

Entities:  

Keywords:  Bipolar disorder; biomarkers; genomic analysis; neuroimaging; peripheral markers

Mesh:

Substances:

Year:  2016        PMID: 27737600     DOI: 10.1080/14737159.2016.1248413

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  11 in total

1.  Resveratrol protects the brain against oxidative damage in a dopaminergic animal model of mania.

Authors:  Samira Menegas; Camila L Ferreira; José Henrique Cararo; Fernanda F Gava; Gustavo C Dal-Pont; Maria L Gomes; Jotele F Agostini; Patrícia Fernanda Schuck; Giselli Scaini; Monica L Andersen; João Quevedo; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2019-03-27       Impact factor: 3.584

2.  Metabolomic Identification of Serum Exosome-Derived Biomarkers for Bipolar Disorder.

Authors:  Yang Du; Ji-Hui Dong; Lei Chen; Hua Liu; Guang-En Zheng; Guang-Yang Chen; Yong Cheng
Journal:  Oxid Med Cell Longev       Date:  2022-01-10       Impact factor: 6.543

3.  Rhythmicity of Mood Symptoms in Individuals at Risk for Psychiatric Disorders.

Authors:  Luísa K Pilz; Alicia Carissimi; Melissa A B Oliveira; Ana Paula Francisco; Raul C Fabris; Madeleine S Medeiros; Marina Scop; Benicio N Frey; Ana Adan; Maria Paz Hidalgo
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

4.  Coadministration of lithium and celecoxib reverses manic-like behavior and decreases oxidative stress in a dopaminergic model of mania induced in rats.

Authors:  Samira S Valvassori; Paula T Tonin; Gustavo C Dal-Pont; Roger B Varela; José Henrique Cararo; Abel Freitas Garcia; Fernanda F Gava; Samira Menegas; Jair C Soares; João Quevedo
Journal:  Transl Psychiatry       Date:  2019-11-13       Impact factor: 6.222

5.  Identification of potential plasma protein biomarkers for bipolar II disorder: a preliminary/exploratory study.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Ru-Band Lu; Liang-Jen Wang; Sung-Chou Li; Chi-Ying Tu; Cheng-Ho Chang; Yung-Chih Chiang; Kuo-Wang Tsai
Journal:  Sci Rep       Date:  2021-05-04       Impact factor: 4.379

6.  Are Mannan-binding Lectine Serin Protease-2 and Alpha-1-microglobulin and Bukinin Precursor the Potential Biomarkers of Manic Episode? A Study via Urinary Proetomic Analysis.

Authors:  Cem Cerit; Mehmet Sarıhan; Ömer Nart; Murat Kasap; Hilmi Yaşar; Gürler Akpınar
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-05-31       Impact factor: 2.582

7.  Distinguish bipolar and major depressive disorder in adolescents based on multimodal neuroimaging: Results from the Adolescent Brain Cognitive Development study®.

Authors:  Yujun Liu; Kai Chen; Yangyang Luo; Jiqiu Wu; Qu Xiang; Li Peng; Jian Zhang; Weiling Zhao; Mingliang Li; Xiaobo Zhou
Journal:  Digit Health       Date:  2022-09-05

8.  Further Evidence of Accelerated Aging in Bipolar Disorder: Focus on GDF-15.

Authors:  Fang Yang; Izabela G Barbosa; Erica L Vieira; Moises E Bauer; Natalia P Rocha; Antonio L Teixeira
Journal:  Transl Neurosci       Date:  2018-03-23       Impact factor: 1.757

Review 9.  Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders.

Authors:  Antonio L Teixeira; Clarissa S Gama; Natalia P Rocha; Mauro M Teixeira
Journal:  Front Psychiatry       Date:  2018-06-14       Impact factor: 4.157

Review 10.  Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders.

Authors:  Anastasia Levchenko; Timur Nurgaliev; Alexander Kanapin; Anastasia Samsonova; Raul R Gainetdinov
Journal:  Heliyon       Date:  2020-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.